Skip to main content

Table 4 Antineoplastic treatment effect on BMD and BMC based on oral calcium and vitamin D3 supplementation in breast cancer patients (n = 40)

From: Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

Parameter No calcium supplement (n = 30) Calcium supplement (n = 10)b
βa p Confidence Interval
95 %
βa p Confidence Interval
95 %
BMD femoral neck (g/cm2) −0.03 <0.001 (−0.036, −0.024) 0.006 0.344 (−0.007, 0.018)
BMD L2-L4 (g/cm2) −0.055 <0.001 (−0.076, −0.035) −0.033 0.003 (−0.052, −0.013)
BMC (kg) −0.047 0.039 (−0.092, −0.003) <0.001 0.987 (−0,052, 0.052)
  1. BMD Bone Mineral Density, BMC Bone Mineral Content
  2. aDetermined by mixed model regression for repeated measures. Calcium supplement and treatment interaction (p ≤ 0.05)
  3. bCalcium and vitamin D3 supplementation (600 mg/200 IU day)